E

Enlivex Therapeutics Ltd
D

ENLV

0.81210
USD
0.04
(5.51%)
مغلق
حجم التداول
4,897
الربح لكل سهم
-0
العائد الربحي
-
P/E
0
حجم السوق
195,755,669
أصول ذات صلة المقالات
المزيد

العنوان: Enlivex Ltd.

القطاع: Healthcare
الصناعة: Biotechnology
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.